Guselkumab as a Possible New Treatment for Psoriasis

Abstract

Introduction: In Mexico it affects approximately 2 million people, with a significant impact on quality of life and difficult to manage. Theoretical framework:The lesion it causes is round, salmon-pink papules and plaques, located on knees, elbows and scalp. The diagnosis is mainly clinical and the treatment will depend on the affected body surface and the location. The drugs considered first line are topical and second line drugs are used systemically, which in many occasions have adverse effects that make attachment difficult. Guselkumab, a drug approved in 2017, is an IgG1 that blocks the p19 subunit of IL-23.Discussion: Guselkumab, which is a monoclonal antibody, provides better patient outcomes compared to the drugs used in current therapeutics. There is little information currently available on Guselkumab since it has only recently been approved, butin all studies it has shown to be superior to other monoclonal antibodies, the main disadvantage being that it is not currently available in Mexico and the long administration time.Conclusion: Researching new drugs helps us to provide the patient with atreatment with the least amount of adverse effects, achieving greater adherence and better control of the disease.

Authors and Affiliations

Ingrid Pamela Rodríguez Minguela ,María Fernanda Gámez Acosta ,Zuleyka Roxana Martínez Martínez , Edit Cano Muñoz , Alfredo López Gómez ,Nallely Olivera Ruiz , Monserrat Espinosa Ramos

Keywords

Related Articles

Protective Factors for Colorectal Cancer

Aspirin and other nonsteroidal anti-inflammatory medicines (NSAIDs) have been shown in a large body of research to be protective against the growth of adenomas and colon cancer. the possible benefit of NSAIDs like aspiri...

Correlation of Maternal Blood Glucose Level to Maternal Delivery and Fetal Outcome in Hasan Sadikin General Hospital

Introduction: Increase of blood glucose level Inpregnant woman correlated with increased risk of maternal morbidity, and problems in labour also affect child outcome. This phenomena cause by physi...

Perioperative Management of the Facial Wounds with Insight of Scar Prevention

Human face is the front side of a head which functions most of all for individual identity. Global culture agrees that scarring on the face reducesattractiveness to the opposite sex; and it drives everyone with a wound...

Paraquat Poisoning – A Brief Overview

Paraquat poisoning in the modern era has become a major medical health problem, due to its high case fatality rate. The toxicological importance of this herbicide is due to its inherent toxicity and lack of spec...

Delirium Management in the Critic Geriatric Patient: An Updated Approach

Delirium or acute confusional syndrome is a common problem in geriatric patients, although itsdiagnosis is often overlooked, especially in its hypoactive form. Risk factors for delirium are previous cognitiv...

Download PDF file
  • EP ID EP740091
  • DOI 10.47191/ijmscrs/v3-i5-04
  • Views 51
  • Downloads 0

How To Cite

Ingrid Pamela Rodríguez Minguela, María Fernanda Gámez Acosta, Zuleyka Roxana Martínez Martínez, Edit Cano Muñoz, Alfredo López Gómez, Nallely Olivera Ruiz, Monserrat Espinosa Ramos (2023). Guselkumab as a Possible New Treatment for Psoriasis. International Journal Of Medical Science And Clinical Research Studies, 3(5), -. https://europub.co.uk/articles/-A-740091